45
Participants
Start Date
March 31, 2006
Study Completion Date
October 31, 2007
MEDI-545
0.3 mg/kg IV (n=6) at Study Day 0
MEDI 545
0.3 mg/kg IV (n=6) at Study Day 0
MEDI-545
0.3 mg/kg IV (n=6) at Study Day 0
MEDI-545
0.3 mg/kg IV (n=6) at Study Day 0
MEDI-545
0.3 mg/kg IV (n=6) at Study Day 0
Hospital for Special Surgery, New York
Columbia University Medical Center, New York
Altoona Center for Clinical Research, Duncansville
Johns Hopkins University, School of Medicine, Baltimore
Florida Medical Clinic, Clinical Research Division, Zephyrhills
Tampa Florida Medical Research Group, Tampa
Clinical Research of West Florida, Clearwater
Ocala Rheumatology Research Center, Ocala
Pinnacle Research Group, Anniston
Center for Innovative Therapy, UCSD School of Medicine, Milwaukee
Froedtert Hospital, Medical College of Wisconsin, Milwaukee
St. Mary's Duluth Clinic, Duluth
Louisiana State University Health Sciences Center-Shreveport, Shreveport
Oklahoma Medical Research Foundation, Oklahoma City
University of Texas Southwestern Medical Center, Dallas
Wallace Rheumatic Study Center, Los Angeles
Oregon Medical Research Center, Portland
University of Washington Div. of Rhematology, Seattle
Center for Rhematology, Immunology, and Arthritis, Fort Lauderdale
Toronto Western Hospital, Toronto
Montreal General Hospital, Montreal
Lead Sponsor
MedImmune LLC
INDUSTRY